Starpharma Holdings Limited (SPL) is a nanotechnology
research and development company. The activities consist of
development and commercialization of dendrimer products for
pharmaceutical, life-science and other applications.
Starpharma Holding Limited has two operating companies,
Starpharma Pty Ltd in Melbourne, Australia and DNT, Inc in
Michigan, USA.